Søgning på udtrykket 'mpox' giver 43 resultater
Dokumenter [2] Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [2]
Denne guideline omfatter konkret håndtering af mistænkte og bekræftede tilfælde af mpox med det formål at diagnosticere mpox, behandle tilfældet samt forebygge smittespredning samt forholdsregler ifm. vaccination mod infektionen.
Kalender [1]
1. oktober, Jernesalen, SSI og Online
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Journal of the American Medical Association
15.10.2024
As the mpox virus continues to spread in Africa, the World Health Organization (WHO) has launched a global emergency response plan to limit transmission. As of June 2024, the agency reported, the outbreak has resulted in nearly 100 000 confirmed cases and 200 deaths, mostly in the Democratic Republic of Congo, but also in such neighboring countries as Burundi and Kenya. Both Sweden and Thailand have reported a single travel-related case each.
Clinical Microbiology and Infection
15.10.2024
On August 14, 2024, WHO's Director-General, Dr. Tedros Adhanom Ghebreyesus, declared Mpox a Public Health Emergency of International Concern (PHEIC). This declaration followed a surge in Mpox cases, particularly those caused by clade Ib of the virus, in the Democratic Republic of the Congo and neighbouring African countries [1]. While the global spotlight has primarily focused on adult populations, especially men who have sex with men (MSM), The paediatric risk from Mpox remains significantly underrecognise…
Emerg Microbes Infect
12.10.2024
Volume 13, Issue 1, December 2024 .
Clinical Infectious Diseases
8.10.2024
Abstract . Introduction . Since its global reemergence in 2022, monkeypox (mpox) has demonstrated increased incidence and severity among people with human immunodeficiency virus (HIV [PWH]). Predictors of mpox diagnosis, vaccination, and outcomes among PWH are limited.Methods . We included PWH with primary care visits after 1 January 2022 at 9 US sites participating in the Centers for AIDS Research Network of Integrated Clinic Systems Network. We identified mpox diagnosed between 1 June 2022 and 31 May 2023…
Clinical Microbiology and Infection
6.10.2024
The current epidemiological situation regarding mpox, a zoonotic viral disease caused by the monkeypox virus (MPXV), is complex. Multiple simultaneous epidemics involving distinct clades of MPXV are occurring across different geographic regions, each affecting distinct at-risk populations. Particularly concerning is the emergence of clade Ib, about which much remains unknown.
American Journal of Respiratory and Critical Care Medicine
2.10.2024
American Journal of Respiratory and Critical Care Medicine, Volume 210, Issue 7, Page P1-P2, October 1, 2024.
BMC Infectious Diseases
1.10.2024
. Abstract. . Background. Since May 7 2022, mpox has been endemic in many countries which has attracted the attention of health authorities in various countries and made control decisions, in which vaccination is the mainstream strategy. However, the shortage of vaccine doses and the reduction of protective efficacy have led to unresolved issues such as vaccine allocation decisions and evaluation of transmission scale. . …
Lancet
27.09.2024
More than a million doses have also been promised to African countries in the coming year. Paul Adepoju reports.
Lancet Infectious Diseases
19.09.2024
Adaptations to sexual behaviour due to mpox were widespread, dynamic, and responded to evolving individual risk perceptions. We propose that the decline in mpox transmission seen at the end of 2022 resulted primarily from a combination of behavioural adaptation and naturally acquired immunity. As mpox vaccination is an important preventive measure, stark vaccine inequity highlights the need to increase access to mpox vaccines.
Emerg Microbes Infect
19.09.2024
Volume 13, Issue 1, December 2024 .
BMC Infectious Diseases
18.09.2024
. Abstract. . Background. Mpox is a severe viral zoonosis that has emerged as a public health concern due to its potential for human-to-human transmission and severe illness. Understanding its clinical manifestations is crucial for effective management and control. Several systematic reviews have assessed various manifestations of Mpox. This umbrella review synthesizes evidence on Mpox’s manifestations across different org…
BMC Infectious Diseases
11.09.2024
…act. . Background. Formal assessment of a surveillance system’s features and its ability to achieve objectives is crucial for disease control and prevention. Since the implementation of the mpox surveillance system in Cameroon, no evaluation has been conducted. . . . Methods. In a cross-sectional study, we assessed the performance of the mpox surveillance sys…
Lancet Infectious Diseases
7.09.2024
On Aug 14, WHO declared the worsening mpox situation in Africa a Public Health Emergency of International Concern. Esther Nakkazi reports.
Lancet
30.08.2024
Gavi's US$2·5 billion Day Zero Financing Facility aims to avoid delays in acquiring vaccines for new pandemics. Ann Danaiya Usher reports.
International Journal of Infectious Diseases
27.08.2024
On 14 August 2024, Director General of the World Health Organization (WHO) declared the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa a public health emergency of international concern (PHEIC).[1] This came only one year after the end of the 10-month long emergency state in 2022/2023, and day after the continental declaration of mpox as a public health security concern.[2] In the year leading to the current declaration, the global burden of mpox ca…
Lancet
23.08.2024
A little over 15 months ago, WHO concluded that the 2022–23 multicountry outbreak of mpox no longer represented a Public Health Emergency of International Concern (PHEIC). This week, rapidly mounting infections and deaths have led the agency to once again declare mpox a PHEIC. The announcement on Aug 14 followed a similar declaration by the Africa Centres for Disease Control and Prevention (Africa CDC) the day before, marking the first time that Africa CDC has designated an outbreak as a Public Health Eme…
Lancet
23.08.2024
A scrabble for vaccines is likely to take place amid the spread of clade 1b mpox. Paul Adepoju reports.
Science Advances
21.08.2024
Science Advances, Volume 10, Issue 34, August 2024.
AIDS
15.08.2024
Objective: . To evaluate the prevalence and characteristics of concurrent bacterial sexually transmitted infections (bSTIs) among individuals with mpox. Design: . Prospective cohort study of participants aged 18 years or older with confirmed mpox conducted in Rio de Janeiro, Brazil. This cross-sectional analysis include only participants who underwent bSTI testing at baseline between June 2022 and January 2024. Methods: . Participants were offered testing for chlamydia/gonorrhea (NAAT, anorectal swabs)…
PLoS One Infectious Diseases
10.08.2024
by Darwin A. León-Figueroa, Joshuan J. Barboza, Abdelmonem Siddiq, Ranjit Sah, Mario J. Valladares-Garrido, Alfonso J. Rodriguez-Morales . Background The increase in mpox incidence underscores the crucial need to understand and effectively address prevention, early detection, and agile response to this disease. Therefore, the present study aims to determine the knowledge and attitude towards mpox. Methods A systematic review and comprehensive literature meta-analysis were conducted using prominent databa…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
14.10.2024
The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially. . Reuters Health Information
Medscape Infectious Diseases
11.10.2024
U.S. health officials have identified a cluster of cases caused by an mpox variant that are resistant to Siga Technologies' antiviral tecovirimat, branded as TPOXX, in five. . Reuters Health Information
Morbidity and Mortality Weekly Report (MMWR)
11.10.2024
This report describes a cluster of mpox cases cause by tecovirimat-resistant mpox.
Morbidity and Mortality Weekly Report (MMWR)
11.10.2024
This report describes mpox risk among men who have sex with men and transgender persons who reported close contact with a person with mpox.
Medscape Infectious Diseases
5.10.2024
The World Health Organization authorized Abbott Laboratories' mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster. . Reuters Health Information
Medscape Infectious Diseases
24.09.2024
U.S. President Joe Biden will announce on Tuesday the donation of 1 million mpox vaccine doses and at least $500 million to African countries to support their response to. . Reuters Health Information
Medscape Infectious Diseases
20.09.2024
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years. . Medscape Medical News
Medscape Infectious Diseases
18.09.2024
In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in preventing mpox infection. . Medscape Medical News
Medscape Infectious Diseases
17.09.2024
The UK government has ordered more than 150,000 doses of Bavarian Nordic's mpox vaccine to boost its preparedness against a new form of the virus currently spreading in. . Reuters Health Information
ECDC Epidemiological Update
17.09.2024
In 2024, over 24 000 confirmed or suspected mpox cases due to MPXV clade I and clade II, including over 600 deaths, have been reported from Africa Union Member States, including over 5 000 confirmed cases.
ECDC Epidemiological Update
17.09.2024
In 2024, over 24 000 confirmed or suspected mpox cases due to MPXV clade I and clade II, including over 600 deaths, have been reported from Africa Union Member States, including over 5 000 confirmed cases.
Medscape Infectious Diseases
14.09.2024
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people in the world’s poorest. . Reuters Health Information
Medscape Infectious Diseases
13.09.2024
Canada is donating 'up to 200,000' doses of mpox vaccine, a government spokesperson said on Wednesday. . Reuters Health Information
ECDC Epidemiological Update
10.09.2024
Since the beginning of mpox monitoring in 2022, and as of 31 July 2024, over 100 000 confirmed cases of mpox due to monkeypox virus (MPXV) clade I and clade II, including over 200 deaths among confirmed cases, have been reported by more than 120 countries globally.
Medscape Infectious Diseases
7.09.2024
Democratic Republic of Congo received its first batch of mpox vaccines on Thursday, which health authorities hope will help curb an outbreak that has prompted the U.N. to. . Reuters Health Information
Morbidity and Mortality Weekly Report (MMWR)
6.09.2024
This report describes cases of clade II mpox among people traveling on commercial airline flights.
ECDC Epidemiological Update
3.09.2024
Since the beginning of mpox monitoring in 2022 and until 31 July 2024, 102 977 confirmed cases of mpox due to MPXV clade I and clade II, including 219 deaths, have been reported by 121 countries globally, according to WHO (2022-24 Mpox (Monkeypox) Outbreak: Global Trends (shinyapps.io)). All cases of MPXV clade I have been reported from the African continent apart from one reported by Sweden and one by Thailand.
Medscape Infectious Diseases
31.08.2024
Scientists studying the new mpox strain that has spread out of Democratic Republic of Congo say the virus is changing faster than expected, and often in areas where experts. . Reuters Health Information
ECDC Epidemiological Update
29.08.2024
There has been an increase in the number of people infected with monkeypox virus (MPXV) clade I in the Democratic Republic of the Congo (DRC) since November 2023.
ECDC Epidemiological Update
26.08.2024
There has been an increase in the number of people infected with monkeypox virus (MPXV) clade I in the Democratic Republic of the Congo (DRC) since November 2023.